financetom
Business
financetom
/
Business
/
Morgan Stanley's Michael Grimes in talks for role in Trump administration, WSJ reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Morgan Stanley's Michael Grimes in talks for role in Trump administration, WSJ reports
Jan 22, 2025 7:01 PM

(Reuters) - Michael Grimes, a technology banker with Morgan Stanley, is in talks to leave the bank for a position in U.S. President Donald Trump's administration, the Wall Street Journal reported on Wednesday, citing people familiar with the discussions.

It wasn't immediately clear what specific role Grimes is pursuing, the report said, but suggested that he may be working with the Department of Government Efficiency, or DOGE, an advisory group focused on implementing significant cuts to the U.S. government.

DOGE, led by Tesla CEO Elon Musk, has ambitious goals of dismantling entire federal agencies and cutting three-quarters of federal government jobs.

A few sources told the WSJ that Grimes' role in the administration could also be something more general.

Last November, Trump named Musk to the role aimed at creating a more efficient government, further boosting the influence of the world's richest man, who had donated millions to support Trump's election campaign.

Musk was supposed to co-lead the department with former Republican presidential candidate Vivek Ramaswamy, though the latter recently stepped down to campaign for elected office.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tyler Technologies Secures Digital Government Solutions Contract With New Jersey State
Tyler Technologies Secures Digital Government Solutions Contract With New Jersey State
Sep 13, 2024
11:01 AM EDT, 09/12/2024 (MT Newswires) -- Tyler Technologies ( TYL ) said Thursday it has clinched a three-year contract with the state of New Jersey to provide digital government solutions. The contract is extendable for two additional years, it said. The company also said the state has extended for another year a separate contract with Tyler for credit card...
Zenas Biopharma, Inc IPOs Tomorrow, Here's What You Need To Know
Zenas Biopharma, Inc IPOs Tomorrow, Here's What You Need To Know
Sep 13, 2024
Zenas BioPharma, Inc (NASDAQ:ZBIO) IPO will take place September, 13 on the NASDAQ exchange under the ticker ZBIO. The company is offering shares at an expected price between $16.00 and $18.00 per share with an insider lock-up period of 180 days ending on March 12, 2025. See also: Benzinga IPO Calendar About Zenas BioPharma, Inc Zenas BioPharma, Inc is a...
Air Canada says government should be ready to prevent pilots from striking
Air Canada says government should be ready to prevent pilots from striking
Sep 13, 2024
(Reuters) - Air Canada said on Thursday that the federal Canadian government should be prepared to intervene to prevent a pilots' strike that could begin as early as next week. Spokesman Christophe Hennebelle, speaking by phone, said the airline was still committed to reaching a deal but accused the union representing pilots of making unreasonable demands. ...
Johnson & Johnson Unit Submits Marketing Application in Europe for Nipocalimab to Treat Generalized Myasthenia Gravis
Johnson & Johnson Unit Submits Marketing Application in Europe for Nipocalimab to Treat Generalized Myasthenia Gravis
Sep 13, 2024
10:50 AM EDT, 09/12/2024 (MT Newswires) -- Johnson & Johnson ( JNJ )-owned (JNJ) Janssen-Cilag International said Thursday it filed a marketing authorization application with the European Medicines Agency for nipocalimab to treat generalized myasthenia gravis, a chronic autoimmune disease. The submission is supported by phase 3 study data which showed nipocalimab's safety and tolerability were consistent with other studies....
Copyright 2023-2026 - www.financetom.com All Rights Reserved